DE3766472D1 - Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten. - Google Patents

Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten.

Info

Publication number
DE3766472D1
DE3766472D1 DE8787309454T DE3766472T DE3766472D1 DE 3766472 D1 DE3766472 D1 DE 3766472D1 DE 8787309454 T DE8787309454 T DE 8787309454T DE 3766472 T DE3766472 T DE 3766472T DE 3766472 D1 DE3766472 D1 DE 3766472D1
Authority
DE
Germany
Prior art keywords
tetrahydroisochinolin
thromboxane
antagonists
derivatives
carbonic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787309454T
Other languages
English (en)
Inventor
Graham John Durant
Andrew Derrick Gribble
Robert Antony Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868625739A external-priority patent/GB8625739D0/en
Priority claimed from GB878715274A external-priority patent/GB8715274D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of DE3766472D1 publication Critical patent/DE3766472D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8787309454T 1986-10-28 1987-10-26 Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten. Expired - Lifetime DE3766472D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868625739A GB8625739D0 (en) 1986-10-28 1986-10-28 Pharmaceutically active compounds
GB878715274A GB8715274D0 (en) 1987-06-30 1987-06-30 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
DE3766472D1 true DE3766472D1 (de) 1991-01-10

Family

ID=26291459

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787309454T Expired - Lifetime DE3766472D1 (de) 1986-10-28 1987-10-26 Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten.

Country Status (11)

Country Link
US (1) US4812573A (de)
EP (1) EP0266949B1 (de)
JP (1) JPH01503233A (de)
AU (1) AU600992B2 (de)
CA (1) CA1296011C (de)
DE (1) DE3766472D1 (de)
DK (1) DK160550C (de)
ES (1) ES2036213T3 (de)
GR (1) GR3001267T3 (de)
PT (1) PT86000B (de)
WO (1) WO1988003137A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613222B1 (fr) * 1987-04-03 1991-06-14 Guigon Nadine Composition pour les soins locaux de l'epiderme, notamment du cuir chevelu
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
HU198458B (en) * 1987-12-30 1989-10-30 Chinoin Gyogyszer Es Vegyeszet Process for producing 2-aminoisoquinoline derivatives and pharmaceutical compositions comprising these compounds
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
DZ2446A1 (fr) * 1997-03-18 2003-01-11 Smithkline Beecham Plc Nouveaux composés
WO1999016752A1 (en) * 1997-09-30 1999-04-08 Molecular Designs International, Inc. β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING
DE19934272A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Neue antivirale Mittel
CN1217936C (zh) * 1999-12-28 2005-09-07 卫材株式会社 含有磺酰胺的杂环化合物
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
DE60325025D1 (de) 2002-02-15 2009-01-15 Glaxo Group Ltd Modulatoren des vanilloidrezeptors
AR040126A1 (es) 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
ES2576477T3 (es) * 2006-08-07 2016-07-07 Janssen Pharmaceutica Nv Proceso para la preparación de derivados de 1,2,3,4-tetrahidroisoquinolina sustituidos
ES2617868T3 (es) 2008-08-22 2017-06-20 Baxalta GmbH Derivados de carbonato de bencilo poliméricos
JP2012525386A (ja) 2009-05-01 2012-10-22 アエリエ・ファーマシューティカルズ・インコーポレーテッド 疾患の治療のための二重機構阻害剤
KR102568079B1 (ko) 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
US9840468B1 (en) * 2016-12-30 2017-12-12 Aerie Pharmaceuticals, Inc. Methods for the preparation of 6-aminoisoquinoline
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28034E (en) * 1972-12-14 1974-06-04 Alkylsulfinylalkyl- and sulfonyl- alkyl-i,z,j,x.tetrahydroisoqijinolines
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4321254A (en) * 1980-09-26 1982-03-23 Smithkline Corporation Antiallergic imidodisulfamides
US4350698A (en) * 1981-09-25 1982-09-21 Smithkline Corporation Antiallergic imidosulfamides
US4536510A (en) * 1983-07-22 1985-08-20 Smith Kline Beckman Corporation Method of antagonizing the effects of thromboxane

Also Published As

Publication number Publication date
US4812573A (en) 1989-03-14
PT86000A (en) 1987-11-01
JPH01503233A (ja) 1989-11-02
WO1988003137A1 (en) 1988-05-05
EP0266949B1 (de) 1990-11-28
DK160550C (da) 1991-09-09
ES2036213T3 (es) 1993-05-16
DK160550B (da) 1991-03-25
CA1296011C (en) 1992-02-18
PT86000B (pt) 1990-08-31
AU600992B2 (en) 1990-08-30
AU8108187A (en) 1988-05-25
EP0266949A1 (de) 1988-05-11
GR3001267T3 (en) 1992-08-25
DK351788D0 (da) 1988-06-24
DK351788A (da) 1988-06-24

Similar Documents

Publication Publication Date Title
DE3766472D1 (de) Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten.
DE3785808T2 (de) Mischungen von dicyanatestern von dihydroxyphenolen.
ATE113610T1 (de) Ester von alginsäure.
DE3783802D1 (de) Laufflaeche von luftreifen.
DE3780933T2 (de) Herstellung von aminoalanen.
DE3685384D1 (de) Vorbereitung von emulsionen.
DE3486138T2 (de) Analogen von wachstum befreiendem faktor.
DE3856076D1 (de) Nachweis von flüssigkeitsströmungen
DE3773964D1 (de) Nachweis von magnetischen unstetigkeiten.
DE3786928D1 (de) Verpackung von schleifmitteln.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DE68906938T2 (de) Einstellung des chargenverhaeltnisses von fluessigkeitsgemischen.
DE68921340D1 (de) Herstellung von epoxinitraten.
DE3874011T2 (de) Ueberempfindlichmachung von silberhalogenid enthaltender emulsion.
DE3761048D1 (de) Umsetzungsprodukte von bis-glycidylthioethern.
ATE58725T1 (de) Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten.
DE68911503D1 (de) Wiedergewinnung von urokinaseverbindungen.
DE3775861D1 (de) Erstarrung von fluessigkeitenfilmen.
DE360604T1 (de) Umlauf von fluessigen proben.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
DE3587341D1 (de) Epoxidation von propylen.
DE3767799D1 (de) Herstellungsverfahren von dichlorohydrin.
DE3766873D1 (de) Herstellung von substituierten dichlormethylpyridinen.
DE3884014D1 (de) Mono- und Diepoxidderivate von 23-Deoxy-LL-F28249-Verbindungen.
DE3765295D1 (de) Synthese von hochreinem 5-chlorisophthaloylchlorid.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee